Skip to content
Wired News Engine – Lifestyle
Author:
Evaxion
Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026
July 17, 2026
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
July 12, 2026
Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop
July 1, 2026
Evaxion receives Prix Galien UK Award for Best digital health solution
June 12, 2026
Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia
June 11, 2026
Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress
May 12, 2026
Evaxion announces business update and first quarter 2026 financial results
May 7, 2026
Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026
May 4, 2026
Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer
April 27, 2026
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
April 17, 2026
1
2
Next Page
→